BenQ Medical Technology Corporation (TPEX:4116)
Taiwan · Delayed Price · Currency is TWD 40.45
+0.30 (0.75%)
At close: Mar 6, 2026
BenQ Medical Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 78.17 | 104.83 | 114.58 | 180.24 | 28.84 |
Depreciation & Amortization | 269.13 | 249.51 | 224.45 | 222.03 | 97.07 |
Other Amortization | - | 5.71 | 4.78 | 4.23 | 3.97 |
Loss (Gain) From Sale of Assets | -17.25 | 0.9 | 0.03 | -3.85 | -0.06 |
Loss (Gain) From Sale of Investments | -8.8 | - | -5.13 | - | - |
Loss (Gain) on Equity Investments | - | - | -5.55 | -3.44 | -1.79 |
Provision & Write-off of Bad Debts | 3.59 | 0.37 | 0.87 | 1.44 | - |
Other Operating Activities | 140.65 | 118.59 | 146.57 | 118.12 | 17 |
Change in Accounts Receivable | -55.97 | -7.33 | -1.45 | -90.49 | -4.73 |
Change in Inventory | -120.56 | -191.85 | -40.81 | 1.32 | -7.07 |
Change in Accounts Payable | -32.41 | 59.13 | -26.42 | 40.29 | 2.99 |
Change in Unearned Revenue | 5.83 | -3.03 | -23.79 | 30.93 | - |
Change in Other Net Operating Assets | 96.37 | -114.61 | 54.21 | -17.99 | -14.88 |
Operating Cash Flow | 358.75 | 222.22 | 442.35 | 482.84 | 121.35 |
Operating Cash Flow Growth | 61.44% | -49.76% | -8.39% | 297.90% | -19.89% |
Capital Expenditures | -93.91 | -170.09 | -133.47 | -76.89 | -30.26 |
Sale of Property, Plant & Equipment | 85.37 | 8.09 | 5.45 | 25.6 | 0.43 |
Cash Acquisitions | -19.43 | -23.26 | - | 76.24 | - |
Sale (Purchase) of Intangibles | -5.34 | -5.4 | -5.81 | -2.94 | -2.67 |
Investment in Securities | -43.6 | 68.59 | -128.68 | -140.67 | -62.99 |
Other Investing Activities | -2.86 | -11.15 | -16.47 | -6.88 | -3.28 |
Investing Cash Flow | -79.76 | -133.22 | -278.98 | -125.54 | -98.77 |
Short-Term Debt Issued | 313.47 | 134.23 | - | 73.85 | - |
Long-Term Debt Issued | 540 | 316.09 | 871 | 235 | 360 |
Total Debt Issued | 853.47 | 450.32 | 871 | 308.85 | 360 |
Short-Term Debt Repaid | - | - | -14.6 | - | -29.96 |
Long-Term Debt Repaid | -844.67 | -313.46 | -519.35 | -266.36 | -168.83 |
Total Debt Repaid | -844.67 | -313.46 | -533.95 | -266.36 | -198.8 |
Net Debt Issued (Repaid) | 8.8 | 136.86 | 337.06 | 42.49 | 161.2 |
Common Dividends Paid | -73.53 | -89.13 | -165.61 | -77.14 | -44.57 |
Other Financing Activities | -126.47 | -109.11 | -484.01 | -58.92 | -24.49 |
Financing Cash Flow | -191.2 | -61.38 | -312.57 | -93.56 | 92.15 |
Foreign Exchange Rate Adjustments | -1.66 | 5.06 | -0.07 | 18.32 | 0.07 |
Net Cash Flow | 86.14 | 32.68 | -149.28 | 282.05 | 114.8 |
Free Cash Flow | 264.84 | 52.14 | 308.88 | 405.95 | 91.09 |
Free Cash Flow Growth | 407.99% | -83.12% | -23.91% | 345.66% | -20.84% |
Free Cash Flow Margin | 5.04% | 1.09% | 6.80% | 9.28% | 6.22% |
Free Cash Flow Per Share | 5.93 | 1.16 | 6.89 | 9.05 | 2.04 |
Cash Interest Paid | - | 34.01 | 27.83 | 17.58 | 3.86 |
Cash Income Tax Paid | - | 112.08 | 109.93 | 65.29 | 16.24 |
Levered Free Cash Flow | 124.48 | -8.6 | 224.2 | -135.76 | 71.13 |
Unlevered Free Cash Flow | 152.37 | 12.79 | 241.66 | -124.61 | 73.57 |
Change in Working Capital | -106.75 | -257.69 | -38.25 | -35.94 | -23.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.